SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001341004-23-000121
Filing Date
2023-04-28
Accepted
2023-04-28 16:30:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A; AMENDMENT NO. 6 sc13da6.htm SC 13D/A 32009
  Complete submission text file 0001341004-23-000121.txt   33284
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Subject) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91017 | Film No.: 23867007
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O APPLIED THERAPEUTICS, INC. 340 MADISON AVENUE, 19TH FLOOR NEW YORK NY 10173
Business Address
Shendelman Shoshana (Filed by) CIK: 0001775490 (see all company filings)

Type: SC 13D/A